Vermillion Releases Data from 494-Patient Study Supporting OVA1
August 03, 2012
Vermillion Releases Data from 494-Patient Study Supporting OVA1
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Vermillion's Q1 Revenues Decline 28 Percent, CEO Page Stepping Down
May 18, 2012 / ProteoMonitor - Vermillion Sends Quest Notice of Default Alleging Breach of Strategic Alliance Agreement
May 24, 2013 / ProteoMonitor - Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - Vermillion Inks CRADA with Army to Evaluate OVA1
April 17, 2013 / GenomeWeb Daily News